NextcureNXTC
13F holders, Q3 2025 (September 30)16holders
1famous investor
$5.86avg. 13F price*
At the end of Q3 2025, 16 institutions reported holding Nextcure Inc. (NXTC) in their 13F filings. The largest holders were Sofinnova Investments, Inc. ($1.3M), Affinity Asset Advisors, LLC ($1.1M) and Pfizer Inc ($924K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Nextcure Inc.
- CUSIP
- 65343E207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
No earlier quarter to compare with.
Ownership 16 holders
| Sofinnova Investments, Inc. | 0.08% | Add +0.1% | 222,654 | $1.3M |
| Affinity Asset Advisors, LLC | 0.11% | Add +0.1% | 191,882 | $1.1M |
| Pfizer Inc | 0.21% | Add +1101.7% | 157,646 | $924K |
| Vanguard Group Inc. | 0.00% | Reduce -6.3% | 67,983 | $398K |
| Cable Car Capital, LP | 0.28% | Add +0.1% | 63,178 | $370K |
| Acadian Asset Management LLC | 0.00% | Reduce -9.8% | 36,675 | $213K |
| BlackRock, Inc. | 0.00% | Reduce -0.7% | 31,086 | $182K |
| Renaissance Technologies | 0.00% | Reduce -32.0% | 28,334 | $166K |
| Geode Capital Management, LLC | 0.00% | Add +2.1% | 19,521 | $114K |
| Sio Capital Management, LLC | 0.02% | Add +0.1% | 10,940 | $64K |
| Barclays PLC | 0.00% | Add +0.1% | 5,626 | $33K |
| UBS Group AG | 0.00% | Reduce -41.3% | 601 | $4K |
| JPMorgan Chase & Co. | 0.00% | Reduce -3.0% | 61 | $357 |
| BNP Paribas Financial Markets | 0.00% | Reduce -0.1% | 32 | $188 |
| Bank of America Corp. | 0.00% | Add +1.2% | 23 | $134 |
| Citigroup Inc. | 0.00% | Reduce -100.0% | 1 | $6 |
"% of holder's portfolio" is NXTC's weight in each manager's 13F, not the share of Nextcure Inc. the manager owns.